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RESEARCH ARTICLE

Decreased tubuloglomerular feedback response in high-fat diet-induced
obesity
Sumit R. Monu, Hong Wang, D’Anna L. Potter, Tang-Dong Liao, and

Pablo A. Ortiz

Division of Hypertension and Vascular Research, Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan

Abstract
Obesity increases the risk of renal damage, but the mechanisms are not clear. Normally, kidneys autoregulate to keep the glomerular capillary pressure (PGC), renal blood ﬂow, and glomerular ﬁltration rate in a steady state. However, in obesity, higher
PGC, renal blood ﬂow, and glomerular ﬁltration rate are noted. Together, these may lead to glomerular damage. PGC is controlled
mainly by afferent arteriole resistance, which, in turn, is regulated by tubuloglomerular feedback (TGF), a vasoconstrictor mechanism. High fat-induced obesity causes renal damage, and this may be related to increased PGC. However, there are no studies
as to whether high-fat diet (HFD)-induced obesity affects TGF. We hypothesized that TGF would be attenuated in obesity caused
by HFD feeding (60% fat) in Sprague–Dawley rats. Sprague–Dawley rats fed a normal-fat diet (NFD; 12% fat) served as the control. We studied 4 and 16 wk of HFD feeding using in vivo renal micropuncture of individual rat nephrons. We did not observe
signiﬁcant differences in body weight, TGF response, and mean arterial pressure at 4 wk of HFD feeding, but after 16 wk of
HFD, rats were heavier and hypertensive. The maximal TGF response was smaller in HFD-fed rats than in NFD-fed rats, indicating an attenuation of TGF in HFD-induced obesity. Baseline PGC was higher in HFD-fed rats than in NFD-fed rats and was associated with higher glomerulosclerosis. We conclude that attenuated TGF and higher PGC along with hypertension in HFD-fed
obese Sprague–Dawley rats could explain the higher propensity of glomerular damage observed in obesity.
NEW & NOTEWORTHY Reduced tubuloglomerular feedback, higher glomerular capillary pressure, and hypertension in combination may explain the higher glomerular damage observed in high-fat diet-induced obesity.
high-fat diet; kidney; kidney damage; obesity; tubuloglomerular feedback

INTRODUCTION
Obesity is now a global pandemic (1) and a cause of “loss
of health” worldwide. Nearly 70% of the adult United States
population is either overweight or obese. A recent report by
the Centers for Disease Control and Prevention indicated
that in the United States alone, almost 42.4% of people are
obese (2). The Centers for Disease Control and Prevention
also pointed out that parallel to the increase in obesity prevalence, kidney damage is also on the rise (2), and currently
almost 4 million people have obesity-related kidney pathology in the United States alone in the absence of diabetes and
hypertension (3). In addition, according to the National
Institutes of Health and the United States Renal Data
System, obesity is strongly linked to the two top causes of
end-stage renal damage, i.e., diabetes and hypertension (4).
Almost 90% of the diabetic population and 70% of the hypertensive population are either overweight or obese (5–7); thus,
obesity should be considered one of the most important
causes of renal damage. Kidney damage associated with
both diabetes and hypertension costs approximately $127 billion annually to the United States, i.e., almost 19% of allcause medical service cost (8). Once the kidney is damaged,

there is no treatment, and most of the patients either must
go for dialysis for their lifetime or their kidney needs to be
replaced (9, 10). Therefore, in the absence of any treatment
for obesity-related kidney disease and its increasing prevalence, it is critical to understand the pathogenesis of this
disease.
Maladaptation in renal hemodynamics has been implicated as one of the key factors for the renal damage observed
in individuals with obesity (11–13). In obesity, alterations in
renal hemodynamics result in higher glomerular capillary
pressure (PGC), renal blood ﬂow (RBF), and glomerular ﬁltration rate (GFR), but the mechanism behind this is
unclear. These alterations in renal hemodynamics and
higher PGC may expose fragile glomerular cells to higher
pressure and cause glomerular barotrauma, which can
lead to renal damage.
In a normal kidney, RBF is autoregulated by mechanisms
such as tubuloglomerular feedback (TGF), connecting tubule
glomerular feedback, and the myogenic response (14). The
renal artery supplies the blood to the kidneys, and within
the kidneys, each nephron receives blood from the arteriole
called the afferent arteriole. The afferent arteriole branches
out to the glomerular capillaries, and ﬁnally blood leaves the
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nephron through the efferent arteriole (14). Since the afferent arteriole, glomerular capillaries, and efferent arteriole
are all arranged in series, their dynamics are closely interconnected (15). The afferent arteriole and efferent arteriole
regulate inﬂow and outﬂow, respectively, and regulate both
PGC and single-nephron GFR (15). Afferent arteriole constriction results in lower PGC and glomerular plasma ﬂow downstream and may decrease GFR (15). In contrast, efferent
arteriole constriction can increase PGC and single-nephron
GFR (16, 17). TGF causes afferent arteriole constriction in
response to increased NaCl in the macula densa via Na þ K þ -2Cl cotransporter isoform 2 (15, 17). A decrease in TGF
may cause afferent arteriole dilation, and this can reduce renal vascular resistance. Reduced renal afferent arteriole resistance, in turn, can lead to increased RBF and increased
transmission of systemic pressure to the glomerulus, causing
higher PGC (18).
Previous studies by us and others have shown that there is
increased PGC and a decreased TGF response (measured
using the stop-ﬂow pressure method) in a monogenic model
of obesity like the Zucker obese rat (19, 20). However,
whether TGF is attenuated in a high-fat diet (HFD)-induced
obesity in Sprague–Dawley (SD) rats is not known. We
hypothesized that HFD-induced obesity impairs the TGF
response and decreases whole kidney GFR and RBF. SD rats
were fed with a HFD (60% fat) or normal-fat diet (NFD; 12%
fat) for 4 or 16 wk. We used in vivo renal micropuncture
using the stop-ﬂow technique and also measured renal
hemodynamics parameters (RBF and GFR) to understand
whole kidney hemodynamics.

MATERIALS AND METHODS
All animal experiments were approved by the Henry
Ford Health System Institutional Animal Care and Use
Committee and were conducted in accordance with the
National Institutes of Health Guide for the Care and Use of
Laboratory Animals.

Renal Micropuncture Experiments
Male SD rats were obtained from Charles River Laboratories.
We conducted in vivo renal micropuncture experiments to
evaluate the TGF response at two time points, the ﬁrst at 4 wk
of HFD feeding and the second at 16 wk of HFD feeding, as previously described (15, 17). Brieﬂy, thiobutabarbital was used intraperitoneally (125 mg/kg body wt) to anesthetize the rats, and
additional dosages of thiobutabarbital were administered to
HFD-fed rats especially at 16 wk of HFD to reach the plane of
anesthesia to conduct renal micropuncture experiments. The
femoral artery and jugular vein were cannulated to measure
mean arterial pressure (MAP) and to infuse 0.154 M NaCl solution (1.5 mL/h to maintain euvolemia), respectively (21). The
abdomen was cut open through the left lateral side, and a lucite cup was used to place the left kidney. Afterward, salinesoaked cotton or animal fat was used to immobilize the kidney.
Thirty to forty-ﬁve minutes were allowed for equilibration
before the start of the renal micropuncture experiments. First,
stained dye was injected into surface tubules, permitting the
detection of tubule loops with a ﬁnding pipette. This helps in
the identiﬁcation of the course of the tubules. Grease was then
F430

injected into an early segment of the proximal tubule causing a
tubule blockage; afterward, two pipettes were inserted inside
the same tubule. First, a perfusion pipette was inserted downstream from the grease block and attached to the infusion
pump. Second, a pipette for measuring stop-ﬂow pressure (PSF)
was inserted upstream of the grease block and was attached to
a micropressure system (model 900 A, World Precision 99
Instruments, Sarasota, FL). To generate a PSF curve, the late
proximal perfusion (in an orthograde manner) rate was
increased stepwise from 0 to 40 nL/min while PSF was measured. Each of the perfusion rates was maintained until we
observed stable PSF. TGF was calculated as the decrease in PSF
caused by an increase in nephron perfusion (15, 22, 23).

RBF Measurement
After 14 wk of HFD feeding, SD rats were fasted overnight
but allowed free access to drinking water. On the experiment
day, rats were anesthetized with the use of an intraperitoneal
injection of thiobutabarbital (125 mg/kg body wt) and placed
on a heated surgical table to maintain constant body temperature. Tracheotomy was done using PE-240 tubing to allow
free breathing of room air. The femoral artery and vein were
cannulated with PE-50 catheters for MAP measurement and
supplementation of 2 mL/h of 2% BSA (Sigma-Aldrich),
respectively. A midventral abdominal incision was performed, and the intestines were wrapped in moist gauze
and moved to the side of the peritoneal cavity to expose the
left kidney. The renal artery was carefully isolated from the
vein and ﬁtted with a Doppler ﬂow probe (Transonic,
Ithaca, NY) connected to a transit-time perivascular ﬂowmeter (model TS-420, Transonic) to record RBF. The rat
was draped, and 30 min were allowed for stabilization
before RBF measurements, as described elsewhere (24).

Measurement of GFR in Conscious Rats
GFR was measured in conscious and unrestrained rats (16wk HFD-fed rats) using a high-throughput method that
involves the detection of ﬂuorescent FITC-labeled inulin
(TdB Consultancy, Uppsala, Sweden) clearance from blood,
as described elsewhere (25). Basically, predialyzed 20 mg/mL
FITC-inulin solution in saline (2 μL of 2% solution per 1 g
body wt) was administered in bolus via tail vein injection to
rats brieﬂy anesthetized with isoﬂurane. Anesthesia was
discontinued after the administration of inulin, and the
animals regained consciousness. Afterward, 10 μL of blood
were collected at 3, 5, 8, 16, 25, 40, 60, 80, 100, and 120
min after the injection by bleeding the tail. Thereafter,
plasma was separated, and inulin clearance was quantiﬁed using FITC intensity. Fluorescence was measured
using a NanoDrop 3300 Fluorospectrometer (Thermo
Fisher Scientiﬁc, Waltham, MA). GFR was calculated from
the observed decrease in FITC ﬂuorescence using a two-compartment model (the initial fast decay representing the redistribution of FITC-inulin from the intravascular compartment
to the extracellular ﬂuid and the slower phase reﬂecting clearance from plasma). GFR curves were approximated with a
biexponential decay function using OriginPro 9.0 (Origin Lab,
Northampton, MA) software, and GFR values (in mL/min)
were obtained from the ﬁtting parameters using the previously described equation (25).
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Intraperitoneal Glucose Tolerance Test
After 14 wk of HFD feeding, SD rats were used to evaluate
glucose tolerance. Rats were fasted overnight, blood samples
were taken from the tail vein, and glucose was measured
using a glucometer (Bayer Contour Blood glucose meter) at 0
(fasting), 15, 30, 60, 90, and 120 min after an intraperitoneal
injection of glucose (2 g/kg) was given.

Measurement of Albuminuria

of the replicates at each ﬂow rate level. We used a set of
paired t tests, where our multiple testing adjustments were
Hochberg’s method. When our interest shifted to two group
comparisons, we used a group of Student’s t tests, one at
each ﬂow level. Again, a Hochberg’s correction for multiple
testing was used. Individual group comparisons were examined using unpaired Student’s t tests.

RESULTS

Albuminuria was measured every 4 wk starting from 8
to 16 wk of HFD feeding. After 24 h of adaptation to metabolic cages, both HFD- and NFD-fed rats underwent urine
collection for 24 h. The total volume of collected urine was
measured, and aliquots were prepared and centrifuged
twice at 1,200 g at 4 C for 10 min. The supernatants were
then ﬁltered and stored at 80 C until further analysis.
Albuminuria was measured using an ELISA kit (GenWay
Biotech ELISA) following the manufacturer’s instructions;
24-h albuminuria was calculated as urine albumin concentration multiplied by 24-h urine volume output, as
described elsewhere (14).

HFD-fed SD rats gradually increased their weight. HFDfed rats were signiﬁcantly heavier compared with NFD-fed
rats starting at week 8 (NFD: 587 ± 21 g vs. HFD: 654 ± 19 g, P <
0.05; Fig. 1A).
The blood glucose level was slightly, but signiﬁcantly,
higher in HFD-fed rats at the baseline level and remained
elevated even after 2 h of intraperitoneal glucose administration (Fig. 1B), indicative of glucose intolerance at 14 wk of
HFD feeding.

Collection of Kidneys for Histological Experiments

TGF Responses at 4 and 16 wk of HFD Feeding

Animals were anesthetized with thiobutabarbital (125 mg/
kg body wt), and a catheter was placed in the abdominal
aorta below the renal artery. Blood was collected, and plasma
was then isolated for the measurement of insulin and leptin
hormones. The aorta was then clamped above the renal artery, and the kidneys were perfused using 0.9% saline followed by ﬁxation by 4% paraformaldehyde solution. Fixed
kidneys were sent to the histology core at Henry Ford Health
System for further processing for periodic acid-Schiff
staining and hematoxylin and eosin staining. Unstained
and charged slides were used for the measurements of
glomerulosclerosis.

To determine whether HFD-induced obesity was associated with changes in the TGF response, late proximal tubules
were perfused with artiﬁcial tubular ﬂuid, while PSF was
measured at two time points, before obesity developed (at 4
wk) or after rats became fully obese at 16 wk of HFD feeding.
During the experiment, the perfusion rate was increased
from 0 to 40 nL/min stepwise to initiate TGF. The TGF
response was similar in NFD- and HFD-fed rats after 4 wk of
diet (Fig. 2A) but was signiﬁcantly attenuated at 16 wk of
HFD feeding (Fig. 2B). At 16 wk of HFD feeding, PSF was signiﬁcantly higher even at the baseline level when the perfusion rate was 0 nL/min (NFD: 38.7 ± 0.5 mmHg vs. HFD:
41.6 ± 0.8 mmHg, P < 0.05). The maximum TGF response
(calculated by subtracting the PSF value from 0 nL/min perfusion rate to 40 nL/min perfusion rate) was similar between
NFD- and HFD-fed rats at 4 wk of HFD feeding (Fig. 2C) but
was signiﬁcantly attenuated at 16 wk of HFD feeding (Fig.
2D). These data indicate a progressive decline in the TGF
response upon HFD feeding.

Statistical Analysis
All data are expressed as means ± SE; n represents the
number of animals. We used ANOVA for repeated measures
for dependent data and standard ANOVA for independent
data. With two-way designs, an interaction effect was also
tested. However, our primary interest was in the comparison

Eﬀect of HFD Feeding on Body Weight and Glucose
Tolerance

Figure 1. A: body weight after high-fat diet
(HFD) feeding. HFD-fed Sprague–Dawley
(SD) rats weighed signiﬁcantly higher
compared with normal-fat diet (NFD)-fed
rats after 8 wk of HFD feeding. Body
weight for the NFD-fed group vs. body
weight for the HFD-fed group: P < 0.05
and P < 0.01. B: glucose tolerance after
HFD feeding. HFD-fed SD rats exhibited
glucose intolerance after 14 wk of HFD
feeding. Blood glucose was signiﬁcantly
increased in HFD-fed SD rats than in NFDfed rats at baseline, 60 min after intraperitoneal glucose injection, and 120 min after
intraperitoneal glucose injection. Blood
glucose in the NFD-fed group vs. blood
glucose in the HFD-fed group: P < 0.05
and P < 0.001.
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Figure 2. A: tubuloglomerular feedback
(TGF) responses at 4 wk of high-fat diet
(HFD) feeding were similar in both HFDand normal-fat diet (NFD)-fed Sprague–
Dawley (SD) rats and HFD-fed SD rats. B:
TGF responses at 16 wk of HFD feeding
was signiﬁcantly lower in HFD-fed rats
than in NFD-fed SD rats. TGF response in
the NFD-fed group vs. TGF response in
the HFD-fed group: P < 0.05, P < 0.01,
and P < 0.001. C: comparison of maximum TGF response in both HFD- and
NFD-fed rats at 4 wk of feeding. D: comparison of maximum TGF response in
both HFD- and NFD-fed rats at 16 wk of
feeding. Maximum TGF response in the
NFD-fed group vs. maximum TGF
response in the HFD-fed group: P <
0.05.

MAP at 4 and 16 wk of HFD Feeding
To determine whether HFD feeding is associated with an
increase in MAP, we measured MAP in thiobutabarbital
anesthetized rats using a femoral catheter during in vivo renal micropuncture. We did not observe a signiﬁcant difference in MAP at 4 wk of HFD feeding, but at 16 wk of feeding,
MAP was signiﬁcantly higher in HFD-fed rats (anesthetized)
than in NFD-fed rats (Fig. 3, A and B), indicating a gradual
increase in blood pressure upon HFD feeding.

investigated whether HFD feeding in normal SD rats blunts
the TGF response and increases PGC and if this change at the
single nephron level is accompanied by changes in whole
kidney renal hemodynamic parameters, such as RBF, GFR,
and renal damage. We measured the TGF response at two
time points: at 4 wk of HFD feeding (before the development

RBF and GFR at 16 wk of HFD Feeding
We investigated whether there was any change in RBF upon
HFD feeding. Although we observed a trend toward higher
RBF in HFD (Fig. 4A), it did not reach statistical signiﬁcance.
We investigated whether obesity was associated with
hyperﬁltration in HF-fed rats, and for that, we measured
GFR after 16 wk of HFD feeding. We observed a trend toward
higher GFR in HFD-fed rats (Fig. 4B), but it failed to reach
statistical signiﬁcance.

Measurement of Renal Damage in HFD-Fed Rats
Albuminuria (a marker of renal damage) was not found to
be signiﬁcantly higher in HFD-fed rats even after 16 wk of
HFD feeding (Fig. 5A). However, we found that glomerulosclerosis was signiﬁcantly higher after 16 wk of HFD feeding,
indicative of higher renal damage (Fig. 5B).

DISCUSSION
The mechanisms by which HFD-induced obesity causes
renal damage are not well understood. In this study, we
F432

Figure 3. A: mean arterial pressure was similar in high-fat diet (HFD)-fed
Sprague–Dawley (SD) rats compared with normal-fat diet (NFD)-fed SD
rats after 4 wk of HFD feeding measured under thiobutabarbital anesthesia using an intrafemoral catheter. B: mean arterial pressure was signiﬁcantly higher in HFD-fed SD rats than in NFD-fed SD rats after 16 wk of
HFD feeding measured under thiobutabarbital anesthesia using an intrafemoral catheter. Mean arterial pressure in the NFD-fed group vs. the
HFD-fed group: P < 0.05.
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Figure 4. A: renal blood ﬂow (RBF) in high-fat diet (HFD)-fed Sprague–
Dawley (SD) rats compared with normal-fat diet (NFD)-fed SD rats after 14
wk of HFD feeding. B: glomerular ﬁltration rate (GFR) in HFD-fed SD rats
compared with NFD-fed SD rats after 14 wk of HFD feeding. gkw, grams
kidney weight.

of obesity) and at 16 wk of HFD feeding (when HFD-fed rats
weighed signiﬁcantly more). Our results show that the TGF
response was unaltered at 4 wk of HFD feeding but was signiﬁcantly attenuated at 16 wk of HFD feeding. At 16 wk of
HFD feeding, RBF and GFR remained unchanged, whereas
blood pressure was higher. There was no difference in proteinuria between NFD- and HFD-fed rats, but glomerulosclerosis was signiﬁcantly higher in HFD-fed rats after 16 wk of
feeding.
HFD-fed SD rats gradually started weighing more compared with NFD-fed SD rats, which became signiﬁcant after
8 wk of feeding, and this difference further increased over
time (Fig. 1). In addition to the increased body weight
upon HFD feeding, these rats developed insulin resistance
observed after 14 wk of HFD feeding similar to what has
been previously reported (26). Higher PGC could be detrimental for the fragile glomerular microvessels in the long term
and has been implicated in causing glomerular barotrauma

leading to renal damage in various renal disease models
such as high-protein diet (27, 28), subtotal nephrectomy (29),
and genetic models of obesity like Zucker rats (15, 22). The in
vivo micropuncture experiments conducted in this study
revealed no elevation of PGC after 4 wk of feeding in the
HFD-fed group, but this was signiﬁcantly higher after 16 wk
of HFD feeding even when the perfusion rate was zero, i.e.,
in the absence of TGF. This ﬁnding is similar to our previous
ﬁnding in Zucker obese rats, wherein we found higher PGC in
the absence of any tubular perfusion (14). We do not know
what changes occurred in afferent glomerular microvessels
or efferent arterioles between 4 wk of HFD feeding and 16 wk
of HFD feeding, but these may be related to either a reduced
myogenic response or increased efferent arteriole constriction (14). A decrease in the myogenic response could allow
systemic pressure to get transmitted to the glomerulus and
could elevate PSF. A recent study by Polichnowski et al. (30)
suggested that the myogenic response remains unaltered after 10 wk in 45% HFD-fed rats using transfer function analysis. However, in the present study, we fed SD rats with 60%
of fat diet and for 16 wk as opposed to 10 wk; thus, we may
still speculate that the chronic HFD feeding, such as of 16
wk, could have decreased the intrinsic myogenic contractility in response to the higher systemic pressure, which could
have increased PSF. In fact, a previous study has shown that
the myogenic response is signiﬁcantly reduced in a monogenic model of obesity such as Zucker obese rats (31).
Another rationale for increased PSF after 16 wk of HFD feeding could be further constriction of the efferent arteriole in
16 wk of HFD-fed rats as hypothesized in obesity (32, 33). To
our knowledge, no study exists that has directly explored the
role of the efferent arteriole in alterations of renal hemodynamics in the context of HFD-induced obesity. However, in
Zucker obese rats, constriction of the efferent arteriole has
been previously reported (34). In addition, it is also interesting to note that there was no signiﬁcant difference in MAP
between the NFD- and HFD-fed groups after 4 wk of feeding.
However, after 16 wk, MAP was signiﬁcantly higher in the
HFD-fed group. This could be another reason for higher
pressure transmission to the glomerulus in this group, especially when renal autoregulation is decreased. We have

Figure 5. A: albuminuria, a marker of renal damage, was not
found to be higher in high-fat diet (HFD)-fed Sprague–
Dawley rats even after 16 wk of feeding. B: glomerulosclerosis was signiﬁcantly higher in HFD-fed rats compared with
normal-fat diet (NFD)-fed rats after 16 wk of feeding. P <
0.05, NFD-fed group vs. HFD-fed group.
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previously reported that TGF has a vasodilatory effect on the
efferent arteriole (at least in vitro; 35), and therefore one may
speculate that since TGF is attenuated in the HFD-fed group,
the efferent arteriole might have constricted resulting into
higher PGC.
Our data show attenuated TGF at 16 wk of HFD along with
high blood pressure. To our knowledge, a relationship
between high blood pressure and differences in TGF has not
been established. We and others have measured the TGF
response in various hypertensive animal models and failed
to establish a directional cause-effect relationship. For example, TGF is attenuated in hypertensive Dahl salt-sensitive
rats on a high-salt diet, whereas TGF is enhanced in spontaneously hypertensive rats or Milan hypertensive rats (22, 36,
37). The TGF response is attenuated in normotensive uninephrectomized rats and mildly hypertensive obese Zucker
rats (14, 15). In some cases, HFD was shown to enhance the
renin-angiotensin system (38, 39), and this may indirectly
€ ller-Suur et
affect the TGF response. In an elegant study, Mu
al. (40) altered renal renin content up to 1,000-fold using
various animal models (heminephrectomized rats, two-kidney Goldblatt hypertensive rats, and DOCA and salt-loaded
rats) but failed to ﬁnd a correlation with TGF responses. Our
group has previously shown that in normotensive rabbits,
angiotensin II enhances TGF (41). Therefore, we would
expect that the HFD, through potential actions on the reninangiotensin system, would enhance the TGF response, but
we observed the opposite. These data suggest that the HFD is
likely blunting TGF through mechanisms that are independent from the increased blood pressure.
We decided to study TGF in the HFD-induced obesity
model because this model resembles more closely what is
observed in humans with obesity with respect to its polygenic metabolic and cardiovascular response to excessive caloric intake from fats (42). Our ﬁnding that a HFD induces
hypertension in SD rats is in sync with other previously
reported ﬁndings (30, 43).
Our results also demonstrated, for the ﬁrst time, that TGF
remains unchanged at 4 wk of HFD feeding but was signiﬁcantly attenuated by 16 wk on HFD in SD rats. The mechanisms behind this observation are largely unclear. TGF is
initiated by Na þ reabsorption by Na þ -K þ -2Cl cotransporters at the macula densa segment of the nephron, which, in
turn, releases adenosine (44). We and others have previously
shown that the released adenosine could cause vascular constriction by acting on the adenosine type A1 receptor (A1R)
present on the wall of the afferent arteriole and elicits TGF
(35, 44). It is possible that adenosine-A1R signaling gets
impaired upon HFD feeding, and that could have resulted
into reduced TGF, but, to our knowledge, there is no study
showing alterations of this TGF signaling pathway by HFD.
We have previously reported that in Zucker obese rats,
another vasodilatory renal intrinsic feedback mechanism,
the connecting tubule glomerular feedback mechanism, was
signiﬁcantly higher. This could be elevated also in HFD-fed
rats and possibly have attenuated the TGF response. The
connecting tubule glomerular feedback mechanism is initiated by the epithelial Na þ channel in the connecting tubule,
and its expression was found to be increased in HFD-fed
mouse kidneys (45), but it is unclear whether this occur in
the rat. Numerous studies have also suggested that nitric
F434

oxide synthesized by the macula densa suppresses TGF (46).
Nitric oxide inhibition by Nx-nitro-L-arginine methyl ester
administration in conscious, chronically instrumented high
fat-fed, obese-prone SD rats increased renal vascular resistance by 39% and decreased RBF by 16%, indicating higher
renal nitric oxide production (30). In contrast, minimal
effects of Nx-nitro-L-arginine methyl ester were seen in
obese resistant SD rats, suggesting that higher nitric oxide
production in the macula densa could be another player in
the attenuated TGF response observed in our 16-wk HFD-fed
group. These hypotheses of a reduced TGF response in the
HFD-fed model need to be tested in future studies.
Although we have observed a reduction in the TGF
response as well as an elevation in PGC, we failed to observe
any signiﬁcant elevation of either RBF or GFR, and the reason behind this is not clear. However, it is worth noting that
we only studied TGF responses or PGC using accessible surface cortical nephrons, and it is possible that the renal cortical and medullary circulation are affected unequally in HFDfed SD rats. This may explain why we did not see increases
in either RBF or GFR at whole kidney level. This possibility
also needs further investigation.
Although we did not observe any increase in RBF or GFR
despite an elevation of PGC and a reduction in the TGF
response, we did observe signiﬁcantly higher glomerulosclerosis in HFD-fed SD rats, while proteinuria was similar.
Others have also shown podocyte effacement (47) and mesangial expansion in HFD-induced obesity in rodent models
(38, 48,49). This indicates that an attenuated TGF response
and higher PGC may be sufﬁcient to cause glomerular damage in the absence of whole kidney hyperﬁltration or hyperperfusion similar to what has been previously proposed (30).
In summary, our study provides the ﬁrst direct evidence
of TGF resetting in HFD-induced obesity. Sixteen weeks of
HFD in SD rats also showed higher PGC and MAP in association with higher renal damage, indicating that these factors in combination could potentially contribute to renal
damage.
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